HER2 Support Group Forums - ImmunoGen, Inc. Announces Clinical Data For T-DM1 Used In Combination With Pertuzumab

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- Breast Cancer Newsfeed (https://her2support.org/vbulletin/forumdisplay.php?f=52)

- - ImmunoGen, Inc. Announces Clinical Data For T-DM1 Used In Combination With Pertuzumab (https://her2support.org/vbulletin/showthread.php?t=48138)

News	12-17-2010 05:11 AM

ImmunoGen, Inc. Announces Clinical Data For T-DM1 Used In Combination With Pertuzumab

ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology, announced the presentation of the first clinical data for trastuzumab-DM1 (T-DM1) used in combination with pertuzumab for first-line treatment of HER2+ metastatic breast cancer (mBC)...

More...

Unregistered

02-03-2011 09:21 AM

Re: ImmunoGen, Inc. Announces Clinical Data For T-DM1 Used In Combination With Pertuz

Is Pertuzumab approved by FDA or it could be use in clinical trials only?

chrisy

02-03-2011 11:27 AM

Re: ImmunoGen, Inc. Announces Clinical Data For T-DM1 Used In Combination With Pertuz

Not approved by fda yet

All times are GMT -7. The time now is 04:10 PM.